| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $96.3M | +72.4% |
| R&D Expense | $320.5M | +48.7% |
| SG&A Expense | $84.2M | +46.9% |
| Operating Income | -$308.4M | -42.1% |
| Income Tax | $0 | — |
| Net Income | -$281.7M | -32.8% |
| EPS (Basic) | -$2.91 | -29.9% |
| EPS (Diluted) | -$2.91 | -29.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $61.3M | -54.1% |
| Short-term Investments | $374.9M | -22.3% |
| Accounts Receivable | $38.5M | +343.5% |
| Current Assets | $502.1M | -20.7% |
| Total Assets | $705.6M | -23.4% |
| Current Liabilities | $114.1M | +40.3% |
| Stockholders' Equity | $483.9M | -28.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$248.2M | -52.4% |
| Capital Expenditures | $35.6M | -29.9% |
| Investing Cash Flow | $166.8M | +151.5% |
| Financing Cash Flow | $9.2M | -98.0% |
| Free Cash Flow | -$283.8M | -32.9% |